MKI67 and hepatocellular carcinoma: In contrast to previous studies focusing on individual markers, this study integrates multi-dimensional analyses, including bioinformatics, immunohistochemistry, transcriptomic profiling, and clinicopathological correlation, to comprehensively elucidate the expression patterns and prognostic implications of CK19, Ki67, and β-catenin in HCC.